Pfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
Pfizer said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results.
Pfizer and other vaccine makers like Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against respiratory viruses that typically surge around the same time of the year.and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study.one step closer to winning a potential regulatory approval for a combination shot for Covid and the flu.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna doses 1st participant in phase 3 clinical trial of combo flu, COVID vaccineThe company said a combo vaccine could raise overall coverage rates.
Read more »
Moderna's joint flu/COVID-19 vaccine undergoing widespread testingJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
'For Shame': Pfizer to Charge $1,390 for Lifesaving Covid Drug That Costs Just $13'Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many,' said one consumer advocate.
Read more »
'Daylight Robbery': Pfizer Condemned for Hiking US Covid Vaccine Price by 10,000% Above Cost'While health workers and the vulnerable continue to go unvaccinated in developing countries, Pfizer is shamelessly fleecing the public for ever-greater sums of money,' said one campaigner.
Read more »
Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccineCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Read more »
Moderna’s stock snaps record losing streak as Cathie Wood’s ETF boosts stakeBiotech’s stock plunged 25% in nine-day losing streak to close Monday at a three-year low
Read more »